Showing results (201-210 of 589) with videos related to
Sort By:
Pageof 59
Expert Review of Anticancer Therapy|August 26, 2010
Prognostic factors for local recurrence following breast-conserving treatment in young womenMarc A Bollet, Youlia M Kirova, Alain Fourquet, et al.Brain Research Bulletin|August 12, 2019
Neurochemical evidence that cysteamine modulates amphetamine-induced dopaminergic neuronal activity in striatum by decreasing dopamine release: an in vivo microdialysis study in freely moving ratsAngelina Rakovska, Daniel Javitt, Polina Petkova-Kirova, et al.Prilozi|February 22, 2013
Early prognosis in patients with community-acquired severe sepsis and septic shock: analysis of 184 consecutive casesK Grozdanovski, Z Milenkovic, I Demiri, et al.European Journal of Gynaecological Oncology|July 20, 1999
Metastasis of a breast carcinoma in a mature teratoma of the ovaryY M Kirova, F Feuilhade, C de Baecque-Fontaine, et al.European Journal of Haematology|April 17, 2018
The role of radiotherapy as salvage and/or consolidation treatment in relapsed/refractory and high-risk diffuse large B-cell lymphomaEric Grignano, Jérémy Laurent, Bénédicte Deau, et al.Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|October 25, 2012
[A case of cutaneous mammary re-irradiation]J Jacob, J-Y Pierga, V Fourchotte, et al.American Journal of Clinical Oncology|July 16, 2025
Concurrent Trastuzumab Deruxtecan and Radiation Therapy in HER2-positive and HER2-low Metastatic Breast Cancer: Assessing the EfficacyJihane Bouziane, Pierre Loap, Sofiane Allali, et al.Medical Physics|January 28, 2025
Photon mini-GRID therapy for preoperative breast cancer tumor treatment: A treatment plan studyAngela Corvino, Tim Schneider, Jeremi Vu-Bezin, et al.Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 12, 2021
In vitro effects of Trastuzumab Emtansine (T-DM1) and concurrent irradiation on HER2-positive breast cancer cellsF Mignot, Y Kirova, P Verrelle, et al.Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|July 2, 2019
Protontherapy versus best photon for mediastinal Hodgkin lymphoma: Dosimetry comparison and treatment using ILROG guidelinesL M Abbassi, F Goudjil, A Arsène-Henry, et al.Pageof 59